We have identified the presence of a robustly resistant ALDH1+ve subpopulation of cells within our isogenic model of cisplatin-resistant NSCLC cell lines (H460, H1299 and SKMES-1). Here, ALDH1A1 is linked to non-small cell lung carcinoma.